Details for Patent: 12,629,483

« Back to Dashboard

Which drugs does patent 12,629,483 protect, and when does it expire?

Patent 12,629,483 protects XYOSTED (AUTOINJECTOR) and is included in one NDA.

This patent has twenty patent family members in ten countries.

Summary for Patent: 12,629,483

Title:	Syringe shock absorber for use in an injection device
Abstract:	An injection device, for example, an auto-injector of any type, includes a sleeve configured to hold a medicament chamber. The sleeve has a proximal end and a distal end connected by a middle portion. The sleeve may be sufficiently deformable such that it functions as a shock absorbing member to distribute the force exerted on the medicament chamber during use of the injection device. The sleeve may include a plurality of compressible posts spaced about an axis of the sleeve.
Inventor(s):	John Pierre MEHAWEJ, Michael Travanty
Assignee:	Antares Pharma Inc
Application Number:	US19/351,989
Patent Claim Types: see list of patent claims	Use; Formulation; Delivery; Dosage form;

Drugs Protected by US Patent 12,629,483

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-001	Sep 28, 2018		RX	Yes	Yes			Y
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018		RX	Yes	Yes			Y
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-003	Sep 28, 2018		RX	Yes	Yes			Y

International Family Members for US Patent 12,629,483

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2957679
Denmark	3984572
European Patent Office	3177346
European Patent Office	3984572